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Astronauts in space and cancer patients being treated with ion beam radiotherapy can be exposed to charged
particle radiations including energetic protons and heavy ions. These charged particles may be more effective
than photons in inducing cancer as well as in causing non-cancer effects. The latter include acute damage from
large solar particle events to the blood-forming organs and skin, acute and (from heavier ions) late damage to
the central nervous system, and late degenerative damage to the lens of the eye and the cardiovascular, circula-
tory and respiratory systems. The presentations in this session discussed a number of non-cancer effects of
protons and heavier charged particles including acute hematopoietic alterations, potentially detrimental cardio-
vascular and circulatory effects, and lifespan shortening.
Keywords: heavy ion effects; hematopoietic damage; cardiovascular risks; non-cancer radiation effects; life-
span shortening
INTRODUCTION
Astronauts on long duration, exploration missions outside low
Earth orbit (LEO) are exposed to a unique and complex radi-
ation environment that is quite different from exposures
received by terrestrial radiation workers. The space radiation
environment includes constant, low-fluence Galactic Cosmic
Rays (GCRs)—composed predominantly of highly energetic
protons and a small percentage of high-atomic-weight, high-
energy (HZE) particles—and sporadic Solar Particle Events
(SPEs)—composed mostly of energetic protons. Historically,
it has been thought that fatal cancer is the major radiation risk
astronauts face from missions beyond LEO [1],and there have
been extensive efforts made to develop radiation risk models,
such as the NASA Space Cancer Risk model, to estimate
cancer risks and associated uncertainties for space missions
[2].However, recent epidemiology studies suggest that degen-
erative tissue effects, including to the lens of the eye and the
cardiovascular and circulatory systems, could also be a
concern for astronauts [3, 4]. Risks of both early and late
damage to the central nervous system are also a concern [5,6];
these risks are addressed in a separate session of this meeting.
Furthermore, the potential problem of an unpredictably large
SPE causing acute radiation syndrome (ARS) that could
threaten mission performance continues to exist [5, 7]. This
session included presentations discussing acute hematopoietic
alterations, potential detrimental cardiovascular and circulatory
effects, and lifespan shortening following charged particle radi-
ation exposures.
DISCUSSION OF PRESENTATIONS
IN THE SESSION
The first presentation in the session was given by Dr Olga
Smirnova (of the Federal State Unitary Enterprise, Moscow,
Russia) on the dynamics of the cellular components of the
hematopoietic system following radiation exposure. One of
the most radiosensitive tissues/organ systems in mammals is
the hematopoietic system. The risk of hematopoietic damage,
as part of the ARS, from a large SPE during a space mission
has long been recognized [5]. Without sufficient shielding, a
large SPE could result in a whole-body dose of over 0.5 Gy
over several hours [7]. Although the effects of X-rays and
gamma-rays in causing ARS are reasonably well understood,
less is known about the hematopoietic effects from an SPE.
Also, complicating understanding of acute effects from an
SPE is that the protons that are the predominant component of
an SPE have a wide range of energies and dose rates within an
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a fraction, albeit small, of the SPE protons become higher-
LET because of the slowing down of higher energy protons.
NASA currently sets short-term dose limits for astronaut ex-
posure to radiation, e.g. a 250 mGy-Eq 30-day limit to the
blood-forming organ (BFO) [7], but additional understanding
of the magnitude and time-courses of changes in various com-
ponents of the hematopoietic system following radiation expo-
sures could help with the development of effective medical
countermeasures and shielding approaches for astronaut pro-
tection from an SPE. Dr Smirnova presented her development
of biologically motivated mathematical models that describe
the dynamics of three major hematopoietic lineages—throm-
bocytopoietic, granulocytopoietic and erythrocytopoietic—in
irradiated humans. The models consider the stages of develop-
ment of the three lineages and the dose responses of the
changes with time in each lineage following irradiation. Dr
Smirnova shows that the models agree well with the available
human data from photon irradiation, supporting their future
application to radiation risk assessment for astronauts.
Four presentations in the session discussed important topics
related to the effects of heavy ions on the heart or the vascula-
ture/circulatory system. A substantial volume of epidemiology
data has indicated a relationship between high doses of
photons, the common terrestrial radiation, and cardiovascular
disease or degenerative heart changes. At high doses (>5 Gy),
dose-dependent increases in stroke and cardiovascular dis-
eases including pericarditis, coronary artery disease, cardio-
myopathy and valvular disease have been shown in patients
treated for cancers such as breast cancer and Hodgkin’s
lymphoma, as reviewed, e.g., in [8 ]. More recently, accumu-
lating epidemiology data from Japanese atomic bomb survi-
vors and other groups, including occupationally exposed
individuals, provide evidence of excess risk of circulatory and
heart diseases at much lower doses of low-LET radiation and
after much longer time intervals, as reviewed, e.g., in [9].
Based on these low-LET epidemiology data, the risk of
cardiac and circulatory diseases can now be included in risk
models for radiation exposure in astronauts, and that inclusion
is now estimated to increase the percentage REID (Risk of
Exposure-Induced Death) by about 40% compared with that
from carcinogenesis alone [10 ]. However, no information is
available on the effects of high-LET, space-like radiations on
the heart and circulatory systems in humans, and very little in-
formation is available in experimental model systems.
Therefore, there is great uncertainty in the relative biological
effectiveness (RBE) values for cardiovascular/circulatory dis-
eases used in risk modeling, and improved information on
HZE effects at space-relevant doses is critically needed.
Dr David Goukassian of Tufts University School of
Medicine, Boston, USA, gave the first cardiovascular-related
presentation of the session. The work by his team demon-
strates a complex interplay between radiation quality and time
after radiation in terms of effects on heart damage-related end-
points and response to a subsequent experimentally induced
adverse cardiovascular event, an acute myocardial infarct,
AMI. In studies using C57BL6N mice at 9 months of age at
the time of total body irradiation, the team showed that after
50 cGy of 1-GeV protons, there were no discernable effects on
the heart for up to 3 months, but at 10 months there was a con-
siderable decrease in the relaxation function of the heart. In
contrast, only 15 cGy of high-LET, 1-GeV/n iron ions caused
several negative impacts on homeostasis and cardiac function
at the measured times of 1, 3 and 10 months after irradiation.
Subjecting mice to an AMI at varying times after irradiation
gave interesting results in that hearts in proton-irradiated
animals did not show negative effects in post-AMI recovery,
and there may even have been some short-term benefit from
proton irradiation, based on molecular markers of cell survival
and proliferation. On the other hand, iron ion irradiation
appeared to cause significant impairment of the recovery of
the heart from an adverse cardiac event, an AMI. Further
studies on the underlying mechanisms for these effects are
expected to be informative.
Dr Johannes Friess (of the University of Applied Sciences
Aschaffenburg, Germany) presented studies that he and his
colleagues conducted using cultured primary avian cardio-
myocytes exposed to several heavy ion species at GSI
Darmstadt, Germany. In this interesting experimental system,
the team investigates the electrophysiological responses of
cells grown on a microelectrode array and can compare the
results of those functional studies with cell proliferation and
DNA damage assessed immunohistologically. The electro-
physiological studies demonstrated large intersample varia-
tions among cells, which precluded demonstration of any
effects of doses up to 7 Gy of carbon, titanium or nickel ions,
although dose-dependent cell cycle delay and formation of
DNA double-strand breaks were seen. Electrophysiological
approaches are promising for the insight they could provide
on heart function following radiation stress, and it is hoped
that more sensitive methods can be developed.
The third cardiovascular talk was given by Dr Dennis
Kucik, who represented his team from the University of
Alabama, Birmingham, USA. It is thought that endothelium-
dependent vasodilation predisposes humans to the develop-
ment of vascular alterations that can lead to atherosclerosis.
This team has been investigating the effect of space-like radia-
tions on development of atherosclerosis in an apolipoprotein
E-deficient (ApoE
−/-) mouse model [11],which is prone to de-
velopment of atherosclerotic lesions. Mice were exposed to
iron ions at a dose that had previously been shown to cause
atherosclerotic plaques in this model at longer times after ir-
radiation, then aortic rings isolated from the animals at 4–5
weeks were assessed for relaxation. Compared with unirra-
diated controls, aortic relaxation was significantly impaired
after iron ion irradiation, suggesting that alteration of normal
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ic plaques. Given that atherosclerosis is a major factor in car-
diovascular disease, studies such as these that provide insight
into the mechanisms of possible effects of radiation could
make an important contribution to developing understanding
of the riskof cardiovascular diseases in astronauts.
Dr Peter Grabham of Columbia University, New York,
USA, presented the last talk on cardiovascular effects of the
session, the emphasis of his team being on radiation effects
on vasculature. The extensive network of blood vessels, in-
cluding microcapillaries, in the human body presents a poten-
tially important target for the effects of radiation [12], and it
has long been recognized that vascular endothelial cells are
targets for radiation-induced damage. Grabham and his collea-
gues have developed a novel 3D cell culture model using
primary human brain microvascular endothelial cells or
human umbilical vein endothelial cells grown in a collagen
gel, so that (with time in culture) the endothelial cells form
capillary-like tubes with central lumens. Depending on the
stage of development at which the tube-forming cultures are
irradiated, the effects of radiation on growing or mature
vessels can be evaluated. The group has shown that both
protons and iron ions are equally highly effective at inhibiting
vessel formation in immature vessels, but that iron ions are at
least four times more effective than protons at disrupting
mature vessels. They have extended that work to provide inter-
esting new information on molecular mechanisms underlying
the differences. Protons and other ions with LET values≤1
keV/μm inhibit capillary formation by altering the ability of
Protein kinase C (PKC)-dependent motile tips to migrate
through the collagen matrix to meet other migrating cell pro-
cesses. On the other hand, ions with LET values >8 keV/μm
affect the later stages of vasculogenesis by causing vessels to
fail to complete angiogenesis and form tubular structures. The
team has recently published some of these novel data [13].
The last talk presented new data on lifespan shortening
following X-ray or carbon ion exposure in mice of varying
ages. Previous investigations using female mice have indi-
cated that infants are more sensitive to radiation-induced life-
span shortening than mice irradiated in utero or as adults.
With the increase in children being treated with charged par-
ticle therapy, concern exists as to whether the charged par-
ticle exposure could have increased effectiveness compared
with photons for the induction of shortened lifespans, which
may or may not be due to increased cancer incidence. In the
work presented, Dr Shizuko Kakinuma and his colleagues irra-
diated male and female mice of varying ages with gamma rays
or 13–14-keV/μm carbon ions to simulate the entrance LET
prior to the spread-out Bragg peak (SOPB) used in ion beam
therapy. Their data showed that generally female mice were
more susceptible than malesto induction of lifespan shortening,
and the most sensitive time appeared to be when mice were 1
week old, with less sensitivity in utero and as adults, and the
RBE for the effect following carbon ion irradiation was~ 2. It
will be informative to see, in future studies, the pathological
analyses to assess whether the effect is mainly due to increased
cancer incidence and, if so, whether the spectrum of cancers is
the same at varying ages of irradiation. Also of interest will be
whether the spectrum of cancers is the same with carbon ions
as with gamma rays, or differs following irradiation with the
lower LET particle type, as has been shown with higher LET
ions [14].
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